Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · IEX Real-Time Price · USD
0.774
-0.006 (-0.78%)
At close: Mar 28, 2024, 4:00 PM
0.790
+0.016 (2.05%)
After-hours: Mar 28, 2024, 7:57 PM EDT

Total Valuation

MCRB has a market cap or net worth of $117.42 million. The enterprise value is $195.21 million.

Market Cap 117.42M
Enterprise Value 195.21M

Important Dates

The last earnings date was Tuesday, March 5, 2024, before market open.

Earnings Date Mar 5, 2024
Ex-Dividend Date n/a

Share Statistics

MCRB has 151.01 million shares outstanding. The number of shares has increased by 18.44% in one year.

Shares Outstanding 151.01M
Shares Change (YoY) +18.44%
Shares Change (QoQ) +1.43%
Owned by Insiders (%) 5.68%
Owned by Institutions (%) 59.48%
Float 118.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.93
Forward PS 115.12
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.55
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.78

Current Ratio 1.78
Quick Ratio 1.47
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.63

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -32.40%
Return on Capital (ROIC) -63.87%
Revenue Per Employee $542,167
Profits Per Employee -$488,086
Employee Count 233
Asset Turnover 0.36
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.05% in the last 52 weeks. The beta is 2.27, so MCRB's price volatility has been higher than the market average.

Beta (1Y) 2.27
52-Week Price Change -86.05%
50-Day Moving Average 1.02
200-Day Moving Average 2.30
Relative Strength Index (RSI) 37.04
Average Volume (30 Days) 4,678,065

Short Selling Information

The latest short interest is 18.40 million, so 12.18% of the outstanding shares have been sold short.

Short Interest 18.40M
Short Previous Month 16.10M
Short % of Shares Out 12.18%
Short % of Float 15.49%
Short Ratio (days to cover) 3.79

Income Statement

In the last 12 months, MCRB had revenue of $126.33 million and -$113.72 million in losses. Loss per share was -$0.89.

Revenue 126.33M
Gross Profit 126.33M
Operating Income -107.98M
Pretax Income -113.72M
Net Income -113.72M
EBITDA -85.43M
EBIT -100.55M
Loss Per Share -$0.89
Full Income Statement

Balance Sheet

The company has $136.15 million in cash and $213.94 million in debt, giving a net cash position of -$77.79 million or -$0.52 per share.

Cash & Cash Equivalents 136.15M
Total Debt 213.94M
Net Cash -77.79M
Net Cash Per Share -$0.52
Equity / Book Value -44.86M
Book Value Per Share -0.30
Working Capital 76.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$117.35 million and capital expenditures -$7.98 million, giving a free cash flow of -$125.33 million.

Operating Cash Flow -117.35M
Capital Expenditures -7.98M
Free Cash Flow -125.33M
FCF Per Share -$0.98
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -85.48% and -90.02%.

Gross Margin 100.00%
Operating Margin -85.48%
Pretax Margin -90.02%
Profit Margin -90.02%
EBITDA Margin -67.63%
EBIT Margin -79.59%
FCF Margin -99.21%

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.44%
Shareholder Yield -18.44%
Earnings Yield -96.85%
FCF Yield -106.73%

Analyst Forecast

The average price target for MCRB is $6.65, which is 759.06% higher than the current price. The consensus rating is "Hold".

Price Target $6.65
Price Target Difference 759.06%
Analyst Consensus Hold
Analyst Count 5
Revenue Growth Forecast (5Y) -6.83%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MCRB has an Altman Z-Score of -3.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.96
Piotroski F-Score 1